medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2011, Número 4

<< Anterior Siguiente >>

Rev Invest Clin 2011; 63 (4)


Parálisis de Bell. Análisis prospectivo, longitudinal, descriptivo y observacional de los factores pronóstico para su recuperación en pacientes mexicanos

Sánchez-Chapul L, Reyes-Cadena S, Andrade-Cabrera JL, Carrillo-Soto IA, León-Hernández SR, Paniagua-Pérez R, Olivera-Díaz H, Baños-Mendoza T, Flores-Mondragón G, Hernández-Campos NA

Idioma: Ingles.
Referencias bibliográficas: 51
Paginas: 361-369
Archivo PDF: 74.12 Kb.


RESUMEN

Objetivo. Determinar los factores pronóstico de la parálisis facial de Bell en pacientes mexicanos. Material y métodos. Diseño: Análisis prospectivo, longitudinal, descriptivo y observacional. Se incluyeron 251 pacientes diagnosticados con parálisis de Bell del Instituto Nacional de Rehabilitación. Se estudiaron características sociodemográficas, época del año, lado afectado de la cara, síntomas y las opciones terapéuticas para determinar los factores pronóstico para su recuperación. Resultados. El 39% de los pacientes tuvo una recuperación completa y 41.5% tuvo una recuperación incompleta. El estado civil, género, etiología, síntomas, lado afectado de la cara, grado de parálisis –según la escala de House-Brackmann– y el tratamiento no resultaron factores pronósticos significativos para la recuperación. La edad › 40 años (OR = 2.4, IC 95% 1.3-4.3, p = 0.002) y la ausencia de terapia física (OR = 6.4, IC 95% 1.4-29.6, p = 0.006) resultaron factores pronósticos significativos para la recuperación incompleta. La parálisis familiar resultó ser un factor pronóstico protector contra una recuperación incompleta (OR = 0.54, IC 95% 0.28-1.01, p = 0.039). Este factor de protección fue solamente significativo en los pacientes femeninos (OR = 0.41, p = 0.22), pero no en los pacientes masculinos (OR = 1.0, p = 0.61). Conclusiones. La proporción de casos con la recuperación incompleta es alta. La edad › 40 años y la ausencia de la terapia física fueron los únicos dos factores pronósticos significativos para una recuperación incompleta.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ljostad U, Okstad S, Topstad T, Mygland A, Monstad P. Acute peripheral facial palsy in adults. J Neurol 2005; 252: 672-6.

  2. Billue JS. Bell’s palsy: an update on idiopathic facial paralysis. Nurse Pract 1997; 22: 97-100.

  3. Gilbert SC. Bell’s palsy and herpesviruses. Herpes 2002; 9: 70-3.

  4. Morgan M, Moffat M, Ritchie L, Collacott I, Brown T. Is Bell’s palsy a reactivation of varicella zoster virus? J Infect 1995; 30: 29-36.

  5. Peitersen E. Bell’s palsy: The spontaneous course of 2500 peripheral facial nerve palsies of different etiologies. Act Otolaryngol Suppl 2002; 549: 4-30.

  6. Wakisaka H, Hato N, Honda N, Takahashi H, Kisaki H, Murakami S, et al. Demyelination associated with HSV-1-induced facial paralysis. Exp Neurol 2002; 178: 68-79.

  7. Yanagihara N, Hyodo M. Association of diabetes mellitus and hypertension with Bell’s palsy and Ramsay Hunt syndrome. Ann Otol Rhinol Laryngol Suppl 1988; 137: 5-7.

  8. Furuta Y, Fukuda S, Chida E, Takasu T, Othan F, Inuyama Y, Nagashima K. Reactivation of herpes simplex virus type 1 in patients with Bell’s palsy. J Med Virol 1998; 54: 162-6.

  9. Linder T, Bossart W, Bodmer D. Bell’s palsy and Herpes simplex virus: Fact or mystery? Otol & Neurol 2005; 26: 109-13.

  10. Morrow MJ. Bell’s palsy and Herpes Zoster oticus. Curr Treat Options Neurol 2000; 2: 407-16.

  11. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell’s palsy and herpes simplex virus: identification of viral DNA in endoneural fluid and muscle. Ann Inter Med 1996; 124: 27-30.

  12. Hato N, Matsumoto S, Kisaki H, Wakisaka H, Honda N, Gyo K, et al. Efficacy of early treatment of Bell’s palsy with oral acyclovir and prednisolone. Otol Neurotol 2003; 24: 948-51.

  13. Tiemstra JF, Khatkhate N. Bell’s palsy: Diagnosis and management. Am Fam Phys 2007; 76: 997-1002.

  14. Shafshak TS. The treatment of facial palsy from the point of view of physical and rehabilitation medicine. Eura Medicophys 2006; 42: 41-7.

  15. Oishi N, Shinden S, Yamashita T, Minami S, Ogura M. A clinical study of Bell’s palsy and factors influencing its prognosis. Nippon Jibiinkoka Gakkai Kaiho 2007; 110: 592-8.

  16. Yeo SW, Lee DH, Jun BC, Chang KH, Park YS. Analysis of prognostic factors in Bell’s palsy and Ramsay Hunt syndrome. Auris Nasus Larynx 2007; 34: 159-64.

  17. Salinas RA, Álvarez G, Ferreira J. Corticosteroids for Bell’s palsy (idiopathic facial paralysis) (Cochrane Review). Cochrane Database of Syst Rev 2009; 15: CD001942.

  18. Allen D, Dunn L. Aciclovir or valaciclovir for Bell’s palsy (idiopathic facial paralysis). Cochrane Database of Syst Rev 2009; 15: CD001869.

  19. Holland NJ, Weiner GM. Recent developments in Bell’s palsy. BMJ 2004; 329: 553-57.

  20. He L, Zhou MK, Zhou D, Wu B, Li N, Kong SY, et al. Acupuncture for Bell’s palsy. Cochrane Database Syst Rev 2007 17: CD002914.

  21. Danielides V, Patrikakos G, Nousia CS, Bartzokas A, Milionis AJ, Lolis C, Skevas A. Weather conditions and Bell’s palsy: five-year study and review of the literature. BMC Neurol 2001; 1: 7.

  22. Gillman GS, Schaitkin BM, May M, Klein SR. Bell’s palsy in pregnancy: a study of recovery outcomes. Otolaryngol Head Neck Surg 2002; 126: 26-30.

  23. Morris AM, Deeks SL, Hill MD, Midroni G, Golstein WC, Mazzulli T, et al. Annualized incidence and spectrum of illness from an outbreak investigation of Bell’s palsy. Neuroepidemiol 2002; 21: 255-61.

  24. Hato N, Murakami S, Gyo K. Steroid and antiviral treatment for Bell’s palsy. Lancet 2008; 371: 1818-20.

  25. González-Cano LL, Sánchez-Ortíz AO, Pérez-Benítez LI. Estandarización de la onda F del nervio facial y su valor pronóstico en la parálisis facial. Rev Mex Med Fis 2001; 4: 113-5.

  26. House JW, Brakmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985; 93: 146-7.

  27. Campbell KE, Brundage JF. Effects of climate, latitude, and season on the incidence of Bell´s palsy in the US armed forces, October 1997 to September 1999. Am J Epidemiol 2002; 156: 32-9.

  28. Clement WA, White A. Idiopathic familial facial nerve paralysis. J Laryngol Otol 2000; 114: 132-4.

  29. Hageman G, Ippel PF, Jansen EN, Rozeboom AR. Familial, alternating Bell’s palsy with dominant inheritance. Eur Neurol 1990; 30: 310-3.

  30. Gregg G. Some observations on Bell’s palsy in Belfast during the period 1949-1958. Arch Phys Med 1961; 42: 602-8.

  31. De Diego JI, Prim MP, Madero R, Gavilán J. Seasonal patterns of idiopathic facial paralysis: a 16-year study. Otolaryngol Head Neck Surg 1999; 120: 269-71.

  32. Beurskens CH, Heymans PG. Physiotherapy in patients with facial nerve paresis: description of outcomes. Am J Otolaryngol 2004; 25: 394-400.

  33. Manikandan N. Effect of facial neuromuscular re-education on facial symmetry in patients with Bell’s palsy: a randomized controlled trial. Clin Rehabil 2007; 21: 338-43.

  34. Adour KK, Hetzler DG. Current medical treatment for facial palsy. Am J Otolaryngol 1984; 5: 499-502.

  35. Adour KK. Medical management of idiopathic (Bell’s) facial palsy. Otolaryngol Clin North Am 1991; 24: 663-73.

  36. Diels HJ. Facial paralysis: is there a role for a therapist? Facial Plast Surg 2000; 16: 361-4.

  37. Wolf SR. Idiopathic facial paralysis. HNO 1998; 46: 786-98.

  38. Jansen JKS, Lomo T, Nicolaysen K, Westgaard RH. Hyperinnervation of skeletal muscle fibers: dependence on muscle activity. Science 1973; 181: 559-61.

  39. Cohan CS, Kater SB. Suppression of neurite elongation and growth cone motility by electrical activity. Science 1986; 232: 1638-40.

  40. Brown MC, Holland RL. A central role for denervated tissues in causing nerve sprouting. Nature 1979; 282: 724.

  41. Waxman B. Electrotherapy for treatment of facial nerve paralysis (Bell’s palsy). Health Technol Ass Reports, Nat Center Health Serv Res 1984; 3: 27.

  42. Cole J, Zimmerman S, Gerson S. Nonsurgical neuromuscular rehabilitation of facial muscle paresis. In: Rubin LR (ed.). The paralyzed face. St. Louis: Mosby-Year Book, Inc; 1991, p 107-12.

  43. Farragher DJ. Electrical stimulation: A method of treatment for facial paralysis. In: Rose FC, Jones R, Vrbova G (eds.). Neuromuscular Stimulation: Basic concepts and clinical implications. New York: Demos; 1989, p. 303-6.

  44. Targan RS, Alon G, Kay SL. Effect of long-term electrical stimulation on motor recovery and improvement of clinical residuals in patients with unsolved facial nerve palsy. Otolaryngol Head Neck Surg 2000; 122: 246-52.

  45. Alakram P, Puckree T. Effects of electrical stimulation on House-Brackmann scores in early Bell’s palsy. Physiother Theory Pract 2010; 26: 160-6.

  46. Hyvärinen A, Tarkka IM, Mervaala E, Pääkkönen A, Valtonen H, Nuutinen J. Cutaneous electrical stimulation treatment in unresolved facial nerve paralysis: an exploratory study. Am J Phys Med Rehabil 2008; 87: 992-7.

  47. Shi X, Yu G, He D. An experimental study on physiotherapy for traumatic facial nerve injury. Zhonghua Kou Qiang Yi Xue Za Zhi 2000; 35: 450-2.

  48. Mysiw WJ, Jackson RD. Electrical stimulation. In: Braddom RL (ed.). Physical medicine and rehabilitation. Philadelphia: WB Saunders Company; 2000, p. 459-87.

  49. Satoh Y, Kanzaki J, Yoshihara S. A comparison and conversion table of “the House-Brackmann facial nerve grading system” and “Yanagihara grading system”. Auris Nasus Larynx 2000; 27: 207-12.

  50. Ahrens A, Skarada D, Wallace M, Cheung JY, Neely JG. Rapid simultaneous comparison system for subjective grading scales for facial paralysis. Am J Otol. 20; 667-71.

  51. Kanerva M, Poussa T, Pitkäranta A. Sunnybrook and House- Brackmann facial grading systems: Intrarater repeatability and interrater agreement. Otolaryngol Head Neck Surg 2006; 135: 865-71.




2020     |     www.medigraphic.com